Live
- Kia to launch compact SUV 'Syros' in India next year
- Completely disagree: Swami Rambhadracharya on Mohan Bhagwat's 'Hindu leaders' remarks
- ISL 2024-25: NorthEast United aim to regain form against struggling Hyderabad
- CII seeks priority sector lending for new and emerging sectors
- Russia's missing An-2 plane found, all aboard alive
- GST recommendations to create business-friendly environment, ensure fairness: Experts
- Army pays tribute to first informant of 1999 Kargil intrusion Tashi Namgyal
- Earnings forecasts of Samsung, SK hynix for Q4 downgraded
- Jaipur crash horror: The U-turn that should never have been there
- FairPoint: The ‘push’ complaint politics may hurt Rahul Gandhi more
Change of guard at CII Telangana
C Shekar Reddy, CMD of CSR Estates Ltd and Sai D Prasad, Executive Director of Bharat Biotech International Ltd
C Shekar Reddy, CMD of CSR Estates Ltd and Sai D Prasad, Executive Director of Bharat Biotech International Ltd were elected as the Chairman and Vice-Chairman of CII Telangana respectively for the year 2023-24.
Hyderabad: C Shekar Reddy, CMD of CSR Estates Ltd and Sai D Prasad, Executive Director of Bharat Biotech International Ltd were elected as the Chairman and Vice-Chairman of CII Telangana respectively for the year 2023-24.
Shekar Reddy a civil engineer with 3 decades of his journey in real estate and most of all in policy making for the sector at both State and national level. With having a vision of a better infrastructural environment for the country has worked towards sector reforms, environmental & customer issues & social responsibility initiatives to bring about a change and accomplish this vision of a better India.
He was instrumental in raising the reputation and strengthening the stature of builders' fraternity in AP, Telangana and India.
Sai Prasad received his undergraduate degree in biochemistry from the University of Wisconsin (USA) and his MBA in Finance and Marketing from the University of Iowa (USA). He has several publications and patents in the areas of vaccines, biotechnology, human genetics, cell biology and molecular biology.
He has been associated with Bharat Biotech since 2004, involved in business and product development for several vaccines and biologics, most of which have become global products today.
